NewAmsterdam Pharma Reports Full Year 2024 Financial Results and Provides Corporate Update
Provided By GlobeNewswire
Last update: Feb 26, 2025
-- EMA submission expected in 2H25 by partner Menarini --
-- Additional data from BROADWAY, BROOKLYN, and TANDEM to be presented throughout 2025 --
Read more at globenewswire.comNASDAQ:NAMS (10/20/2025, 1:41:04 PM)
38.09
+1.69 (+4.64%)
NASDAQ:NAMSW (10/17/2025, 8:00:01 PM)
24.65
-0.34 (-1.34%)
Find more stocks in the Stock Screener
